This webpage explores the treatment of Hepatitis C (HCV) and HIV coinfection, addressing the complexities of managing both infections simultaneously. It discusses antiviral treatment options, potential drug interactions, and strategies for monitoring and managing the dual conditions effectively.
This journal presents a spatial–temporal modeling study examining how city-level sociodemographic and health-related factors influenced the prevalence of antimicrobial-resistant gonorrhea in the U.S. from 2000 to 2019.
This video features Christopher Golden, a neonatologist at Johns Hopkins Children’s Center, discussing the alarming rise in congenital syphilis and its implications for pediatric care.
This guideline provides recommendations for HIV care teams on implementing long-acting injectable HIV treatment, including cabotegravir and rilpivirine.
This information sheet explains the requirement for insurers to cover Pre-Exposure Prophylaxis (PrEP) without cost-sharing.
This information sheet provides guidance on covering the costs of PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis).
This journal examines the role of circular RNAs (circRNAs) in HIV-1 replication, highlighting the discovery that backsplicing of the HIV-1 transcript produces multiple circRNAs that enhance viral replication.
This journal discusses the development of a handheld platform designed for the detection of HIV, utilizing paper-based sample preparation and real-time isothermal amplification.
This journal presents findings from a pilot randomized clinical trial evaluating two brief interventions aimed at increasing HIV pre-exposure prophylaxis (PrEP) uptake among rural people who inject drugs (PWID) attending syringe services programs (SSPs) in Kentucky.
This fact sheet provides a detailed comparison of tuberculosis (TB) treatment regimens, encompassing both drug-sensitive and drug-resistant TB.
